LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $796,000 | -10.9% | 9,239 | -7.7% | 0.01% | -11.1% |
Q2 2022 | $893,000 | -54.2% | 10,007 | -42.2% | 0.01% | -57.1% |
Q1 2022 | $1,949,000 | -34.8% | 17,324 | -10.4% | 0.02% | -38.2% |
Q4 2021 | $2,987,000 | +4.9% | 19,340 | -5.4% | 0.03% | +25.9% |
Q3 2021 | $2,847,000 | -0.6% | 20,434 | -6.4% | 0.03% | +8.0% |
Q2 2021 | $2,863,000 | -35.4% | 21,824 | -25.0% | 0.02% | -41.9% |
Q1 2021 | $4,434,000 | +53.4% | 29,085 | +0.1% | 0.04% | +30.3% |
Q4 2020 | $2,890,000 | +47.9% | 29,060 | +41.8% | 0.03% | +13.8% |
Q3 2020 | $1,954,000 | -20.2% | 20,500 | -6.4% | 0.03% | -12.1% |
Q2 2020 | $2,449,000 | +12.2% | 21,898 | -27.0% | 0.03% | -2.9% |
Q1 2020 | $2,182,000 | -40.8% | 30,011 | -15.1% | 0.03% | +17.2% |
Q4 2019 | $3,687,000 | -2.3% | 35,352 | -6.8% | 0.03% | 0.0% |
Q3 2019 | $3,775,000 | -25.2% | 37,928 | -14.3% | 0.03% | -21.6% |
Q2 2019 | $5,049,000 | -24.1% | 44,232 | -16.4% | 0.04% | -21.3% |
Q1 2019 | $6,655,000 | -3.6% | 52,937 | +4.1% | 0.05% | -13.0% |
Q4 2018 | $6,900,000 | -35.8% | 50,847 | +29.9% | 0.05% | -23.9% |
Q3 2018 | $10,748,000 | +68.5% | 39,156 | +27.2% | 0.07% | +69.0% |
Q2 2018 | $6,378,000 | +36.4% | 30,784 | +8.8% | 0.04% | +13.5% |
Q1 2018 | $4,675,000 | +46.0% | 28,305 | +21.0% | 0.04% | +68.2% |
Q4 2017 | $3,202,000 | +14.2% | 23,386 | +13.5% | 0.02% | +10.0% |
Q3 2017 | $2,805,000 | +22.4% | 20,603 | +9.1% | 0.02% | +25.0% |
Q2 2017 | $2,292,000 | +20.7% | 18,883 | +5.3% | 0.02% | +23.1% |
Q1 2017 | $1,899,000 | -7.0% | 17,941 | -10.7% | 0.01% | -13.3% |
Q4 2016 | $2,041,000 | -24.8% | 20,084 | -24.5% | 0.02% | -31.8% |
Q3 2016 | $2,713,000 | -31.7% | 26,586 | -20.2% | 0.02% | -37.1% |
Q2 2016 | $3,974,000 | +38.6% | 33,320 | +24.4% | 0.04% | +16.7% |
Q1 2016 | $2,867,000 | -15.5% | 26,775 | -14.4% | 0.03% | -9.1% |
Q4 2015 | $3,393,000 | -89.1% | 31,294 | -13.6% | 0.03% | 0.0% |
Q3 2015 | $31,024,000 | +1053.7% | 36,222 | +35.9% | 0.03% | +43.5% |
Q2 2015 | $2,689,000 | +107.2% | 26,651 | +58.4% | 0.02% | +109.1% |
Q1 2015 | $1,298,000 | +99.7% | 16,828 | +60.4% | 0.01% | +57.1% |
Q4 2013 | $650,000 | +179.0% | 10,494 | +94.9% | 0.01% | +133.3% |
Q3 2013 | $233,000 | – | 5,384 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $6,891 | 2.63% |
VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |